PETER VENEZIANO: Open Payments
NPI 1811308554 · CHESTNUT HILL, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,510 in 60 payments from 11 companies in 2025. Trend: 2023 $1,258 · 2024 $1,943 · 2025 $1,510
Food & beverage: $1,510
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 22 | $529 |
| TOLMAR, INC. | 15 | $263 |
| Lilly USA, LLC | 2 | $151 |
| Novo Nordisk Inc | 4 | $110 |
| Antares Pharma, Inc. | 4 | $109 |
| E.R. Squibb & Sons, L.L.C. | 3 | $106 |
| Verity Pharmaceuticals Inc. | 3 | $79 |
| Amgen Inc. | 2 | $57 |
| Azurity Pharmaceuticals, Inc. | 3 | $56 |
| Inspire Medical Systems, Inc. | 1 | $33 |
Products named: AVEED, JATENZO, ZEPBOUND, XIAFLEX, XYOSTED, Wegovy, Tlando, ELIQUIS.
Industry payments across MA — which companies pay providers there.
